RedHill Biopharma Ltd.
RDHL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001553846
In the last 90 days, RedHill Biopharma Ltd. insiders filed 0 open-market purchases and 1 sale; 14 institutions reported holding it in 13F filings for Q2 2026, worth $270.0K in total; no superinvestor holds it.
13F holders, Q4 2025
Institutional positions in RedHill Biopharma Ltd. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 17
- +3 vs. Q3 2025
- Shares held
- 499.5K
- +475.9K (+2,017.8%) vs. Q3 2025
- Total value
- $514.5K
- +$463.3K (+905.3%) vs. Q3 2025
- New holders
- 4
- 3 more added
- Sold out
- 1
- 3 more reduced
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RDHL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 14 | $270.0K |
| Q1 2026 | 16 | $386.5K |
| Q4 2025 | 17 | $514.5K |
| Q3 2025 | 14 | $51.2K |
| Q2 2025 | 12 | $37.9K |
| Q1 2025 | 12 | $80.5K |
| Q4 2024 | 11 | $103.5K |
| Q3 2024 | 11 | $48.8K |
| Q2 2024 | 18 | $719.7K |
| Q1 2024 | 17 | $1.40M |
| Q4 2023 | 19 | $449.2K |
| Q3 2023 | 19 | $781.9K |
| Q2 2023 | 21 | $419.2K |
| Q1 2023 | 20 | $1.20M |
| Q4 2022 | 41 | $1.51M |
| Q3 2022 | 43 | $1.46M |
| Q2 2022 | 48 | $3.89M |
| Q1 2022 | 49 | $11.9M |
| Q4 2021 | 57 | $12.5M |
| Q3 2021 | 61 | $24.5M |
| Q2 2021 | 55 | $49.1M |
| Q1 2021 | 64 | $77.4M |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding RedHill Biopharma Ltd.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Yorkville Advisors Global, LP | 386,593 | $398.2K | 0.27% | +386,593 | New |
| Gagnon Securities LLC | 86,102 | $88.7K | 0.02% | +68,280+383.1% | Added |
| Citadel Advisors LLC | 15,477 | $15.9K | 0.00% | +15,477 | New |
| GAMMA Investing LLC | 4,828 | $4.97K | 0.00% | +4,693+3,476.3% | Added |
| Federation des caisses Desjardins du Quebec | 3,388 | $3.49K | 0.00% | 00.0% | Unchanged |
| Rhumbline Advisers | 2,678 | $2.75K | 0.00% | +910+51.5% | Added |
| Bank of America Corp | 303 | $312 | 0.00% | 00.0% | Unchanged |
| EverSource Wealth Advisors, LLC | 38 | $39 | 0.00% | 00.0% | Unchanged |
| Your Advocates Ltd., LLP | 19 | $20 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 18 | $18 | 0.00% | −5−21.7% | Reduced |
| Garton & Associates Financial Advisors LLC | 15 | $15 | 0.00% | +15 | New |
| Smartleaf Asset Management LLC | 5 | $5 | 0.00% | +5 | New |
| SBI Securities Co., Ltd. | 4 | $4 | 0.00% | −53−93.0% | Reduced |
| Group One Trading, L.P. | 4 | $4 | 0.00% | −7−63.6% | Reduced |
| Vermillion Wealth Management, Inc. | 2 | $2 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 1 | $1 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Rothschild Investment LLC | 0 | $0 | 0.00% | −17−100.0% | Sold out |